Effectiveness of FDG PET in the detection of recurrent squamous cell carcinoma of the head and neck.

被引：0
|
作者：
Li, PY [1 ]
Mozley, PD [1 ]
Zhuang, HM [1 ]
Machtay, I [1 ]
Dinitis, A [1 ]
Rosenthal, DI [1 ]
Alavi, AA [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
122
引用
收藏
页码：32P / 32P
页数：1
相关论文
共 50 条
  • [1] Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG PET.
    Li, PY
    Mozley, PD
    Zhuang, PM
    Alavi, AA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 286P - 286P
  • [2] F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma
    Lee, Jong Cheol
    Kim, Jae Seung
    Lee, Jeong Hyun
    Nam, Soon Yuhl
    Choi, Seung-Ho
    Lee, Sang-Wook
    Kim, Sung-Bae
    Kim, Sang Yoon
    ORAL ONCOLOGY, 2007, 43 (07) : 686 - 692
  • [3] Cost-effectiveness of nivolumab for treatment of platinum-resistant recurrent or metastatic squamous cell carcinoma of the head and neck.
    Carroll, Kate
    Tringale, Kathryn Ries
    Zakeri, Kaveh
    Sacco, Assuntina Gesualda
    Barnachea, Linda
    Murphy, James Don
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Expression of topoisomerase II in squamous cell carcinoma of the head and neck.
    Haines, GK
    Zielinski, M
    Brown, T
    Leyland, J
    Radosevich, JA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A355 - A355
  • [5] Phase II study of cetuximab and lenalidomide in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Taylor, Rodney J.
    Saloura, Vassiliki
    Wong, Richard
    Goloubeva, Olga
    Silpino, Lorna
    de Souza, Jonas
    Seiwert, Tanguy
    Vokes, Everett
    Cohen, Ezra
    Villaflor, Victoria
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [6] Therapy of recurrent and metastatic squamous cell carcinoma of the head and neck. Highlights of the ASCO Meeting 2013
    Hezel, M.
    Kurzweg, T.
    Muenscher, A.
    Schafhausen, P.
    Knecht, R.
    HNO, 2013, 61 (11) : 911 - 913
  • [7] Neoadjuvant and adjuvant nivolumab and lirilumab in patients with recurrent, resectable squamous cell carcinoma of the head and neck.
    Hanna, Glenn J.
    O'Neill, Anne M.
    Jo, Vickie Y.
    Wong, Kristine
    Lizotte, Patrick H.
    Annino, Donald J.
    Goguen, Laura A.
    Kass, Jason I.
    Rettig, Eleni M.
    Sethi, Rosh K. V.
    Lorch, Jochen H.
    Schoenfeld, Jonathan D.
    Margalit, Danielle N.
    Tishler, Roy B.
    Everett, Peter C.
    Desai, Anupam M.
    Paweletz, Cloud P.
    Egloff, Ann Marie
    Uppaluri, Ravindra
    Haddad, Robert I.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Systematic FDG-PET/CT for the detection of recurrent head and neck squamous cell carcinoma 6 months after curative treatment
    Balogova, S.
    Xu, Y.
    Perie, S.
    Kerrou, K.
    Huchet, V.
    Montravers, F.
    Pascal, O.
    Vercellino, L.
    St Guily, J. Lacau
    Talbot, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S184 - S184
  • [9] Recurrent head and neck squamous cell carcinoma
    Wu, S-Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] PET and recurrent squamous cell carcinoma of the head and neck: A surgeon's view
    Goodwin, WJ
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1998, 19 (07) : 1197 - 1197
12345